These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22153673)

  • 1. Are glucocorticoids really deleterious to bone health?
    Roux C
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S211-3. PubMed ID: 22153673
    [No Abstract]   [Full Text] [Related]  

  • 2. Medications associated with fracture risk in patients with rheumatoid arthritis.
    Ozen G; Pedro S; Wolfe F; Michaud K
    Ann Rheum Dis; 2019 Aug; 78(8):1041-1047. PubMed ID: 31092411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Anno S; Koike T
    Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone safety of low-dose glucocorticoids in rheumatic diseases.
    Saag KG
    Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of glucocorticoid-induced osteoporosis: lessons for clinical practice.
    Roux C; Rajzbaum G; Morel G; Legrand E; Laroche M; Hoppé E; Chopin F; Borg S; Biver E; Cortet B; Thomas T
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S222-6. PubMed ID: 22153676
    [No Abstract]   [Full Text] [Related]  

  • 6. Male osteoporosis and glucocorticoid-induced osteoporosis 2nd National ODISSEE Meetings (Osteoporosis: DIagnosis and Surveillance of SEvErity). Foreword.
    Thomas T
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S189-90. PubMed ID: 22153668
    [No Abstract]   [Full Text] [Related]  

  • 7. Are glucocorticoids harmful to bone in early rheumatoid arthritis?
    Lems WF
    Ann N Y Acad Sci; 2014 May; 1318():50-4. PubMed ID: 24739059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors associated with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.
    Ma CC; Xu SQ; Gong X; Wu Y; Qi S; Liu W; Xu JH
    Arch Osteoporos; 2017 Dec; 12(1):33. PubMed ID: 28374332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid-induced Osteoporosis.
    Whittier X; Saag KG
    Rheum Dis Clin North Am; 2016 Feb; 42(1):177-89, x. PubMed ID: 26611558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rheumatoid arthritis plus osteoporosis. How much corticoid will this patient still tolerate?].
    Fassbender WJ
    MMW Fortschr Med; 2012 Feb; 154(3):34. PubMed ID: 22458166
    [No Abstract]   [Full Text] [Related]  

  • 11. Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials.
    Siu S; Haraoui B; Bissonnette R; Bessette L; Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Kraft J; Lynde C; Gulliver W; Keeling S; Dutz J; Pope JE
    Arthritis Care Res (Hoboken); 2015 May; 67(6):754-64. PubMed ID: 25418272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical markers of bone turnover. New aspect. Biochemical bone markers of bone in patients treated with glucocorticoid].
    Yamauchi M
    Clin Calcium; 2009 Aug; 19(8):1092-1100. PubMed ID: 19638692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-induced osteoporosis: is the bone density decrease the only explanation?
    Lespessailles E; Poupon S; Adriambelosoa N; Pothuaud L; Siroux V; Bouillon S; Benhamou CL
    Joint Bone Spine; 2000; 67(2):119-26. PubMed ID: 10769104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures.
    de Villiers TJ
    Climacteric; 2014 Feb; 17(1):101. PubMed ID: 24571030
    [No Abstract]   [Full Text] [Related]  

  • 15. Selecting the optimal treatment for glucocorticoid-induced osteoporosis.
    Chopin F; Hoppé E; Morel G; Biver E; Borg S; Thomas T
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S218-21. PubMed ID: 22153675
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucocorticoid-induced osteoporosis: Insights for the clinician.
    Hayat S; Magrey MN
    Cleve Clin J Med; 2020 Jun; 87(7):417-426. PubMed ID: 32605977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of the treatment of glucocorticoid-induced osteoporosis].
    Asano S; Suzuki A
    Clin Calcium; 2013 Mar; 23(3):401-8. PubMed ID: 23445894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male osteoporosis: who should be treated and how?
    Biver E; Borg S; Chopin F; Hoppé E; Morel G; Cortet B
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S202-7. PubMed ID: 22153671
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology.
    Wall E; Walker-Bone K
    QJM; 2008 Apr; 101(4):317-23. PubMed ID: 18270228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucocorticoid induced osteoporosis].
    Lange U; Müller-Ladner U
    Orthopade; 2007 Apr; 36(4):381-8; quiz 389-90. PubMed ID: 17665509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.